A plateau needs a definition
A few unchanged measurements, a flatter group average and a research-defined plateau are different observations. Before treating a headline as relevant to you, ask what was measured, over how long and in whom. A study graph describes the data included in that analysis. It cannot establish why one person’s weight has changed or what their next clinical step should be. The useful purpose of reading the research is to prepare better questions for the clinician who knows your circumstances.
STEP 5: a two-year semaglutide trial
STEP 5 randomized 304 adults with obesity, or overweight with a weight-related condition, without diabetes. It compared injectable semaglutide 2.4 mg with placebo, both alongside behavioral intervention, over 104 weeks. The authors described average weight reduction flattening around week 60 and remaining broadly maintained afterward. At week 104, mean change was −15.2% with semaglutide and −2.6% with placebo. This demonstrates an average time course within a specific trial, not a deadline by which an individual should reach a particular weight.
The tirzepatide analysis used a working definition
An exploratory post-hoc analysis of SURMOUNT-1 and SURMOUNT-4 examined time to plateau. In SURMOUNT-1, the definition was less than 5% weight change over a 12-week interval and all later 12-week intervals. It included participants with at least 75% study-dose adherence and at least 5% weight loss, with additional dose and measurement requirements. That selected population matters. The analysis was not a universal survey of everyone starting treatment, and its threshold does not mean the scale had to remain completely unchanged.
Source: Horn et al.: time to plateau in SURMOUNT-1 and SURMOUNT-4, Clinical Obesity, 2025
Do not turn the curve into a countdown
Our reading implication is to separate observation from prescription. A flatter study average does not automatically establish treatment failure, and a research definition does not supply an instruction to raise a dose or switch medicine. Nor should a later average plateau become a promise of continuous loss until that date. When comparing claims, ask whether the writer has preserved the study population, definition and time window. If a marketing page jumps directly from a curve to a product recommendation, it has skipped the individual clinical assessment.
Bring a clear question to your clinician
Describe the trend that concerns you and ask how it should be evaluated in the context of your overall care plan. Ask which measurements and records would be useful, what follow-up is appropriate and how your goals should be reviewed. Use the clinician’s instructions for treatment decisions rather than copying an online schedule or another person’s experience. You do not need to diagnose the reason for a plateau before asking for help. The clinical conversation is where your own history, symptoms and priorities can be considered together.
Compare support rather than promised outcomes
For provider shopping, ask how routine follow-up is arranged, whether you can reach a clinician with concerns and what support is included in the recurring fee. The related reviews examine those service details. Neither study ranked affiliate programs or tested the customer experience of a telehealth brand. These trial treatments also should not be treated as evidence that every compounded or differently formulated product has the same trajectory. Keep claims about a medicine’s research separate from claims about the service offering access to care.
Put the questions to work
Compare our researched providers or build your provider checklist.
Explore relevant provider reviews
Use these reviews to compare the published services and terms. Inclusion is a research starting point, not a recommendation for treatment.
Continue your research
Sources & scope
Sources checked October 12, 2026. This guide explains published information and consumer research questions; it is not a clinical evaluation.
- Garvey et al.: STEP 5, Nature Medicine, 2022
- Horn et al.: time to plateau in SURMOUNT-1 and SURMOUNT-4, Clinical Obesity, 2025
Prices and terms can change. Confirm your specific offer directly with the provider.